Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | lapuleucel-T |
Trade Name | |
Synonyms | Neuvenge|APC8024|DN24-02 |
Drug Descriptions |
Neuvenge (lapuleucel-T) is a cellular vaccine of antigen-presenting cells cultured with recombinant Erbb2 (Her2) antigen linked to GMCSF, which stimulates anti-tumor response against Erbb2 (Her2) expressing tumor cells (J Clin Oncol 34, 2016 (suppl; abstr 4513), PMID: 19723649). |
DrugClasses | |
CAS Registry Number | 845680-07-1 |
NCIT ID | C2057 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
lapuleucel-T | lapuleucel-T | 0 | 0 |